hyperplasia, recommended options are either hormone therapy or consideration of a uterine dilatation and curettage (D&C). Patients with atypical hyperplasia on biopsy should undergo a D&C; additionally, referral to a gynecologic oncologist or similar
Search Results
Cervical Cancer Screening
Edward E. Partridge, Nadeem R. Abu-Rustum, Susan M. Campos, Patrick J. Fahey, Michael Farmer, Rochelle L. Garcia, Anna Giuliano, Howard W. Jones III, Subodh M. Lele, Richard W. Lieberman, Stewart L. Massad, Mark A. Morgan, R. Kevin Reynolds, Helen E. Rhodes, Diljeet K. Singh, Karen Smith-McCune, Nelson Teng, Cornelia Liu Trimble, Fidel Valea, and Sharon Wilczynski
Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
David S. Ettinger, Douglas E. Wood, James Stevenson, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Debora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Malcolm DeCamp, Thomas J. Dilling, Jonathan Dowell, Gregory A. Durm, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo Jr, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Trey C. Mullikin, Thomas Ng, Gregory A. Otterson, Sandip P. Patel, Tejas Patil, Patricio M. Polanco, Gregory J. Riely, Jonathan Riess, Theresa A. Shapiro, Aditi P. Singh, Alda Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, and Miranda Hughes
controversies in the diagnosis of mesothelioma: part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers . J Clin Pathol 2013 ; 66 : 847 – 853 . 63. Husain AN
Enrollment Criteria Controversies for Active Surveillance and Triggers for Conversion to Treatment in Prostate Cancer
David D. Buethe and Julio Pow-Sang
, PCA3 scores have been found to be prostate cancer–specific 51 , 52 and unaffected by the presence of prostatitis or prostatic volume/benign prostatic hyperplasia, 53 which historically have been confounders associated with an elevated serum PSA
Strategies to Circumvent Testosterone Surge and Disease Flare in Advanced Prostate Cancer: Emerging Treatment Paradigms
Venkata K. Pokuri, Houman Nourkeyhani, Bodie Betsy, Laurie Herbst, Marcus Sikorski, Edward Spangenthal, Andrew Fabiano, and Saby George
Costello AJ Peters J . Differential response of prostate specific antigen to testosterone surge after luteinizing hormone-releasing hormone analogue in prostate cancer and benign prostatic hyperplasia . BJU Int 2000 ; 85 : 690 – 695 . 9
Screening Mammography for Average-Risk Women: The Controversy and NCCN's Position
Mark A. Helvie and Therese B. Bevers
currently classified as benign, reveal high-risk or premalignant conditions, such as lobular carcinoma in situ or atypical ductal hyperplasia, which allows for alternative risk management decisions and may be preventive. 5 Overdiagnosis Overdiagnosis
The Role of MRI in Breast Cancer Screening
Constance D. Lehman and Robert A. Smith
hyperplasia . Ann Surg Oncol 2007 ; 14 : 1051 - 1057 . 35 Park MJ Cha ES Kang BJ . The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors . Korean J Radiol 2007 ; 8 : 390 - 396 . 36
Use of 18F-FDG PET/CT as an Initial Staging Procedure for Stage II–III Breast Cancer: A Multicenter Value Analysis
Colby J. Hyland, Flora Varghese, Christina Yau, Heather Beckwith, Katia Khoury, William Varnado, Gillian L. Hirst, Robert R. Flavell, A. Jo Chien, Douglas Yee, Claudine J. Isaacs, Andres Forero-Torres, Laura J. Esserman, and Michelle E. Melisko
included hypermetabolic bone lesions (possibly representing bone islands or Schmorl nodes), liver lesions (possible complex cysts, hemangiomas, or focal nodular hyperplasia), thyroid nodules, calcified and noncalcified “too small to characterize” pulmonary
The Biologic Spectrum of Thymic Epithelial Neoplasms: Current Status and Future Prospects
Richard T. Cheney
. Primary thymic epithelial neoplasms: spectrum of differentiation and histologic features . Semin Diagn Pathol 1999 ; 16 : 2 – 17 . 28. Levine GD Rosai J . Thymic hyperplasia and neoplasia: a review of current concepts
Prostate Cancer Screening and Determining the Appropriate Prostate-Specific Antigen Cutoff Values
William J. Catalona and Stacy Loeb
increasing prevalence of benign prostatic hyperplasia (BPH) with advancing age, and a greater risk for death from competing causes. Accordingly, rather than recommending the use of age-specific PSA thresholds, some experts now recommend discontinuing PSA
Mammographic Breast Density: Effect on Imaging and Breast Cancer Risk
Renee W. Pinsky and Mark A. Helvie
breast density describes 4 groups: “N1” as mostly fat, “P1” (less than one fourth of the breast) and “P2” (more than one fourth of the breast) as increasing connective tissue hyperplasia surrounding the ducts, and “DY” as marked mammary dysplasia, which
